SC4HD comprises a group of clinicians and scientists actively involved in the development of cell therapy for Huntington's disease. The consortium aims to provide guidance and guidelines to facilitate progress, as well as to generate a robust clinical development plan.

2018

28

10

3

YEAR ESTABLISHED

MEMBERS

COUNTRIES

CONTINENTS

News

STEERING COMMITTEE

This site was designed with the
.com
website builder. Create your website today.
Start Now